Quantitative SPECT/CT imaging of lead-212: a phantom study

Monika Kvassheim,Mona-Elisabeth R. Revheim,Caroline Stokke
DOI: https://doi.org/10.1186/s40658-022-00481-z
2022-08-05
EJNMMI Physics
Abstract:Lead-212 ( 212 Pb) is a promising radionuclide for targeted therapy, as it decays to α-particle emitter bismuth-212 ( 212 Bi) via β-particle emission. This extends the problematic short half-life of 212 Bi. In preparation for upcoming clinical trials with 212 Pb, the feasibility of quantitative single photon-emission computed tomography/computed tomography (SPECT/CT) imaging of 212 Pb was studied, with the purpose to explore the possibility of individualised patient dosimetric estimation.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?